First JAK Inhibitor Approved for Crohn's Disease Upadacitinib lands indication for moderately to severely active disease in adults May 18, 2023
Addiction Doc Urges Lawmakers to Rethink Methadone Prescribing Restrictions Suicide prevention in traumatic brain injury survivors also on the docket during hearing May 18, 2023
NASH Drug Candidate Comes With 'Serious Risks,' Says FDA Staff Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug May 17, 2023
The Broader Significance of a New Drug for a Rare Form of ALS The tofersen trial offers hope and lessons for the fight against ALS May 15, 2023
Duchenne Muscular Dystrophy Treatment Narrowly Captures Support of FDA Advisors Whether vote means FDA will approve Sarepta's gene therapy remains to be seen May 13, 2023
FDA OKs Hormone-Free Pill for Hot Flashes First-in-class drug works by blocking the NK3 receptor, which plays role in regulating body temp May 12, 2023
Bill to Study Xylazine Passes House, Advances in Senate Measure does not address scheduling the drug, which is frequently added to fentanyl May 12, 2023
FDA Updates Warnings on All Stimulants for ADHD, Other Conditions New language emphasizes potential for misuse, abuse, addiction, and overdose May 12, 2023
FDA Panel Backs Needle-Free Epinephrine for Anaphylaxis Choice of alternative route with nasal spray outweighs possible risks, panelists say May 12, 2023
FDA Relaxes Blood Donation Rules for Gay and Bisexual Men New guidance ditches MSM-specific screening questions in effort to expand eligibility May 11, 2023
Senators Call Out PBMs, Drugmakers for High Prescription Drug Costs This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
FDA OKs First Drug for Agitation in Alzheimer's Dementia Boxed warning on increased mortality risk in elderly patients remains for brexpiprazole May 11, 2023
Sarepta's Duchenne Gene Therapy Does Not Have 'Unambiguous Evidence,' FDA Staff Says Agency reviewers question micro-dystrophin as a surrogate endpoint May 10, 2023
As the COVID PHE Ends, Here's What Doctors Are Carrying Forward Responses range the spectrum, from asking patients to mask, to not changing a thing May 10, 2023
FDA Staff Grapples With Absent Clinical Efficacy Data for Nasal Epinephrine No precedent for approval of noninjectable epinephrine for anaphylaxis, noted agency reviewers May 10, 2023
Proposed Breast Cancer Screening Guidelines Are Good, but Not Enough Specifics for older women, Black women, and those with dense breasts are needed May 09, 2023
FDA Reviewers Raise Multiple Issues on OTC Birth Control Pill Is labeling enough for users to take the drug correctly and self-deselect? May 05, 2023
Democratic Senators Rebuke Cuts to NIH in House-Passed Bill But lawmakers from both parties are "disappointed" with the president's budget proposal May 05, 2023
Forging the Path to a West Nile Vaccine Alternative approaches to licensure are key, says CDC's Carolyn Gould May 04, 2023 video
'Ghost' Provider Networks a Big Problem for Patients, Especially in Mental Health Only 18% of docs called by Senate's "secret shoppers" were really in-network and taking patients May 03, 2023
Feds Spent Even More on PrEP Combo Than Previously Thought New estimate says taxpayers spent over $140 million to study Truvada as HIV prevention May 02, 2023
Why Is One Dose Suddenly Enough for the mRNA COVID Vaccines? FDA and CDC have made yet another questionable decision May 02, 2023
Some Private Companies Charge Hefty Fees to Help Veterans With Disability Claims Unaccredited operators cause headaches for vets Apr 30, 2023
It's a Precarious Path From Dreamer to Doctor DACA recipients face barriers to education and practice Apr 29, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
ACOG PAC Donated Over $1M to Anti-Abortion Legislators Ob/gyn organization maintains stated support for reproductive healthcare, including abortion Apr 28, 2023
More Efforts Needed to Combat Antimicrobial Resistance, Lawmakers Told Witnesses at House hearing push for new drugs and tests, and more infectious disease docs Apr 28, 2023
Patients Living With Long COVID Offer Insight to FDA Agency sought feedback on outcomes that matter most to patients Apr 28, 2023
FDA Extends Trikafta Approval to Even Younger Cystic Fibrosis Patients Patients ages 2 to 5 years now eligible for the triple therapy Apr 27, 2023
FDA OKs First Poop-Based Oral Therapy Vowst approved for preventing recurrent C. difficile infections after antibiotics Apr 27, 2023
Return of 3-Day Rule Will Stress Crowded Hospitals Further Groups call for the 57-year-old policy to be abolished Apr 26, 2023
Be Wary of Amniotic Fluid Eye Drops, FDA Says Agency sends another salvo in battle with birth-tissue industry Apr 24, 2023
FDA Finally OKs Latest MiniMed System for Type 1 Diabetes 780G system first to feature meal detection technology Apr 24, 2023
Thumbs Down From FDA Panel on Plastic Meniscus Replacement Members unimpressed with efficacy, safety data Apr 21, 2023
Who Are the Doctors Suing FDA Over the Abortion Pill? Four physicians are named as plaintiffs alongside the Alliance for Hippocratic Medicine Apr 20, 2023
FDA Panelists Slam Agency's Proposed Opioid Trial Design Advisors said outcomes from an enriched enrollment study would not be broadly generalizable Apr 20, 2023
Antibody-Drug Conjugate Gets FDA Thumbs Up for Untreated DLBCL Adding polatuzumab vedotin to a modified version of R-CHOP significantly improved PFS Apr 20, 2023
ADHD Drug Abuse in Schools; Bizarre Ozempic Dreams; COVID Ups Diabetes Risk Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Apr 19, 2023
FDA Mulling Trial Design Issues for Long-Term Opioids in Chronic Pain Agency advisors will consider pros, cons of an enriched enrollment randomized withdrawal design Apr 17, 2023
FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia Increased mortality risk seen but benefits may outweigh this, panelists say Apr 14, 2023
